MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cansino Biologics Inc (OP:CASBF)

4.600 UNCHANGED
Streaming Delayed Price Updated: 3:12 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.600
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 4.600
Today's Range 4.600 - 4.600
52wk Range 2.600 - 6.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Overseas Growth Gathers Momentum as CanSinoBIO's Global Strategy Unlocks New Opportunities
From CanSino Biologics Inc
Via ACN Newswire
News headline image
CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline
From CanSino Biologics Inc
Via ACN Newswire

Performance

YTD
+2.8%
+2.8%
1 Month
+17.9%
+17.9%
3 Month
+53.3%
+53.3%
6 Month
+15.9%
+15.9%
1 Year
-23.1%
-23.1%

More News

Read More
News headline image
CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America
Via ACN Newswire
News headline image
CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion
Via ACN Newswire
News headline image
CanSinoBIO: From Profit Turnaround to Value Realization as an Innovative Vaccine Leader
Via ACN Newswire
News headline image
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
From CanSino Biologics Inc
Via ACN Newswire
News headline image
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Via ACN Newswire
News headline image
CanSino Receives Another Strong Boost
Via ACN Newswire
News headline image
CanSinoBIO Reports Outstanding H1 2024 Performance
Via ACN Newswire
News headline image
CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
Via ACN Newswire
News headline image
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Via ACN Newswire
News headline image
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership ↗
Via Talk Markets
News headline image
Why Is CanSino Biologics (CASBF) Stock Soaring Today? ↗
Via InvestorPlace
News headline image
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal ↗
Via Talk Markets
News headline image
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal ↗
Via Talk Markets
News headline image
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs ↗
Via Talk Markets

Frequently Asked Questions

Is Cansino Biologics Inc publicly traded?
Yes, Cansino Biologics Inc is publicly traded.
What exchange does Cansino Biologics Inc trade on?
Cansino Biologics Inc trades on the OTC Traded
What is the ticker symbol for Cansino Biologics Inc?
The ticker symbol for Cansino Biologics Inc is CASBF on the OTC Traded
What is the current price of Cansino Biologics Inc?
The current price of Cansino Biologics Inc is 4.600
When was Cansino Biologics Inc last traded?
The last trade of Cansino Biologics Inc was at 08/27/26 03:12 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story